NCT01272037 · MORE INFO

Limitations, agreements, and source contact

Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer · Source last updated 2026-08-28

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement

pi Sponsor Employee: false
restriction Type: LTE60
restrictive Agreement: true

point Of Contact

email: dlew@fredhutch.org
organization: SWOG Statistics and Data Management Center
phone: 206-667-4623
title: Breast Committee Statistician

Complete source fields

certain Agreement

pi Sponsor Employee: false
restriction Type: LTE60
restrictive Agreement: true

point Of Contact

email: dlew@fredhutch.org
organization: SWOG Statistics and Data Management Center
phone: 206-667-4623
title: Breast Committee Statistician

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice